Document is current
Any future updates will be listed below
-
Authors
Elsheikh, Samer https://orcid.org/0000-0002-3796-5709
Möhlenbruch, Markus
Seker, Fatih
Berlis, Ansgar
Maurer, Christoph
Kocer, Naci
Jamous, Ala
Behme, Daniel
Taschner, Christian
Urbach, Horst
Meckel, Stephan
-
Funding
Funding for this research was provided by:
Universitätsklinikum Freiburg
- License Information
-
More Information
Article History
Received: 5 November 2021
Accepted: 18 December 2021
First Online: 20 January 2022
Declarations
:
: F. Seker, C. Maurer, N. Kocer, A. Jamous, D. Behme, C. Taschner and H. Urbach declare that they have no competing interests. A. Berlis: financial interests: Stryker, Microvention, Medtronic, Sequent Medical (Proctor and service-related fees), phenox (lecture honorary, CEC), and Penumbra (lecture honorary). Nonfinancial interests: none. M. Möhlenbruch: financial interests: consultancy: Medtronic, MicroVention, Stryker Neurovascular, phenox*; grants/grants pending: Balt, MicroVention*; payment for lectures including service on speakers bureaus: Medtronic, MicroVention, Stryker Neurovascular. Nonfinancial interests: none. S. Elsheikh: financial interests: research grants from Bracco Suisse S.A., Medtronic, Cerenovus. Travel grant from Medtronic. Nonfinancial interests: none. S. Meckel: financial interests: consultant to Acandis GmbH, Microvention, Stryker, and Novartis Pharma GmbH, speaker fees (modest)/travel grant from Medtronic. Nonfinancial interests: none.
: Due to the retrospective nature of this study, approval of the ethics committee was not obtained. All interventions in this study were clinically indicated. The decision was made in each participating center. Conception of the study and data collection were retrospective.
